Disc Medicine, Inc. (IRON)
NASDAQ: IRON · IEX Real-Time Price · USD
62.26
+1.75 (2.89%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Disc Medicine Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Selling, General & Admin
21.8614.045.765.876.75
Research & Development
69.2633.4425.1728.1734.47
Operating Expenses
91.1347.4830.9334.0441.23
Operating Income
-91.13-47.48-30.93-34.04-41.23
Interest Expense / Income
0006.830.35
Other Expense / Income
-14.8-0.655.04-0.03-0.18
Pretax Income
-76.33-46.83-35.97-40.84-41.4
Income Tax
0.10000
Net Income
-76.43-46.83-35.97-40.84-41.4
Shares Outstanding (Basic)
221121
Shares Outstanding (Diluted)
221121
Shares Change
2046.81%18.34%-41.89%192.28%-
EPS (Basic)
-3.42-45.05-40.95-27.00-80.10
EPS (Diluted)
-3.42-45.05-40.95-27.00-80.10
Free Cash Flow
-73.55-42.4-27.6-32.73-38.76
Free Cash Flow Per Share
-3.30-40.79-31.42-21.65-74.95
EBITDA
-75.94-46.53-35.78-33.69-40.76
Depreciation & Amortization
0.390.30.190.320.29
EBIT
-76.33-46.83-35.97-34.01-41.05
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).